Myxedema coma

DBCOND0020856Endocrine System DiseasesSkin and Subcutaneous Tissue Diseases

Myxedema coma is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Myxedema · Myxoedema coma · Myxoedema · myxedema pre-coma
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0014379ICD-10E03.5SNOMED CT154660000MedDRA10028663UMLSC0027145

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Myxedema coma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In